Wuhan University joins Landing enterprise to create an international platform for cloud based cervical cancer screening
Beijing, China, March 28, 2019. China Maternal and Child Health Care Association and Wuhan University Landing AI Cytology Diagnostic Center launched Landing Med’s Cervical Cancer Screening AI Cloud Diagnostic Platform. As of March 28, 2019, this innovative platform can be accessed from all over the world. Women, especially those from countries supported by the Belt Road Initiative, will be able to benefit from high-quality, low-cost cervical cancer screening services provided by the Chinese artificial intelligence cloud diagnostic platform.
Wuhan University Landing AI Research Center teamed up with multi-disciplinary experts who, after 17 years of development, established a unique system that uses artificial intelligence cytopathological software and Landing Med’s hardware. Landing scanning platform is connected to the Landing cloud platform (Cyto brain). Gererated reports can be sent directly to smartphones or could be remotely reviewed by cytologists before issuing to the patient.
“The goal of releasing an AI cervical cancer screening international cloud platform is to create an intelligent, standardized cervical cancer screening network platform, which can be used by anyone anywhere,” said Dr. Sun Xiaorong, a leading scientist at the Landing Center. “Cross-border cooperation can be carried out through our AI cloud diagnostic platform which currently has a monthly (screening) capacity of 2 million cases. In addition, this platform can support program progress monitoring and quality control, and improve follow-up rates with quick communication with each participant in the program. Many resource issues that we see in rural China are almost identical to those in other countries. Landing’s successful implementation of cloud based cervical cancer screening in which millions of rural women participated so far can be replicated anywhere. Landing has already started pilot projects in countries such as Malaysia and Indonesia where advantages of the cloud approach have been recognized.”
“China Maternal and Child Health Association will actively participate in the promotion of AI cloud diagnostic technology applications,” said Yu Xiaoqian, General Secretary of China Maternal and Child Health Association. “The successful application of this technology in China at the primary health care level shows that China is at the forefront of the world in this field. Our approach can serve as a model for other countries who have similar problem with resources for early detection of cervical cancer.”